Health Condition 1: N461- Oligospermia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Mild (10–15 million sperm/mL) and moderate (5–10 million sperm/mL) Oligospermia. 2. Subjects who are willing to undergo sonological investigations and provide semen and blood samples for laboratory investigations. 3. Subjects Who are willing to sign in written informed consent.
Exclusion criteria
Exclusion criteria: 1. Transgenders 2. Azoospermia 3. Conditions affecting the Testes 4. Liver and Renal disorders 5. Cancer 6. Any other serious systemic ailments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The study drugs safety will be assessed using the following parameters: LFT, RFT, and Urine routine. 2. The study drugs efficacy will be assessed by the increase of the sperm count from the baseline.Timepoint: Laboratory Investigations will be done on 0 and 91st day. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mean Improvement in Quality of Life of Trial participants assessed by Fertiqol. 2. Mean Improvement in increasing sperm motility. 3. To achieve conception/offspring.Timepoint: 1. Laboratory Investigations will be done on 0 and 91st day. 2. Fertiqol will be assessed on the 0 day and 91st day. | — |
Countries
India
Contacts
Central Council for Research in Siddha, Ministry of AYUSH